Track the 코스맥스비티아이 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 코스맥스비티아이 has logged 55 reports. Market capitalisation: €188bn. The latest transaction was disclosed on 26 June 2026 (Other). Among the most active insiders: 서성석. All data is accessible without an account.
55
Insider Decl.
0
Thresholds
·
32 ops.
Buy Volume
·
1 ops.
Sell Volume
24Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,025 of 26,270 companies
54.2
score / 100
Value
68
Quality
41
FCF yld1.2%
Earn yld14%
EV/EBITDA9.3x
ROE13%
Gross mgn21%
Net mgn4.5%
Debt/EBITDA6.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Cosmax BTI is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and manufacturing of pharmaceutical and cosmetic products.